Our scientific staff has extensive experience in preclinical evaluation of anticancer drugs and compound development from preclinical to early clinical stages.

The company offers consulting and preclinical project management services in a large field of preclinical activities, including compound efficacy testing, non-regulatory toxicity assays and target validation.

XenTech scientists apply their knowledge and technological expertise to assist you in project design optimization. XenTech delivers a flexible, tailored approach to all research objectives in preclinical oncology, whether a one-off service or a complete research program.